|

Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)

RECRUITINGSponsored by Heinrich-Heine University, Duesseldorf
Actively Recruiting
SponsorHeinrich-Heine University, Duesseldorf
Started2024-06-01
Est. completion2024-09-30
Eligibility
Age45 Years – 70 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06626386

Summary

The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement results and the influence of the transportation time.

Eligibility

Age: 45 Years – 70 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Men aged from 45 to 70 years
* Informed consent for PSA measurement for prostate cancer screening

Exclusion Criteria:

* Patients unable to give consent

Conditions2

CancerProstate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.